Last quarter (Q ), RegeneRx Biopharmaceuticals's total revenue was $19.19K, a decrease of >-0.01% from the same quarter last year. In Q, RegeneRx Biopharmaceuticals's net income was $-385.20K. See RegeneRx Biopharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 76.76K	$ 76.76K	$ 76.76K	$ 76.76K	$ 76.76K	$ 69.67K
Cost of Revenue	-	-	-	-	-	-
Gross Profit	$ 38.38K	$ 76.76K	$ 76.76K	-	-	-
Operating Expense	$ 3.74M	$ 1.48M	$ -1.41M	$ 1.37M	$ 1.34M	$ 1.39M
Operating Income	$ -1.36M	$ -1.40M	$ -1.33M	$ -1.29M	$ -1.26M	$ -1.32M
Net Non Operating Interest Income Expense	$ -325.53K	$ -325.46K	$ -269.24K	$ -228.82K	$ -142.37K	$ -87.28K
Other Income Expense	$ -76.76K	$ -76.76K	$ -76.76K	-	-	$ -582.90K
Pretax Income	$ -1.69M	$ -1.73M	$ -1.60M	$ -1.52M	$ -1.40M	$ -1.99M
Tax Provision	-	-	-	$ 0.00	$ 0.00	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -1.69M	$ -1.73M	$ -1.60M	$ -1.52M	$ -1.49M	$ -1.99M
Basic EPS	$ -0.01	$ -0.01	$ -0.01	$ -0.01	$ -0.01	$ -0.02
Diluted EPS	$ -0.01	$ -0.01	$ -0.01	$ -0.01	$ -0.01	$ -0.02
Basic Average Shares	$ 430.65M	$ 143.55M	$ 138.59M	$ 133.36M	$ 130.97M	$ 120.72M
Diluted Average Shares	$ 430.65M	$ 143.55M	$ 138.59M	$ 133.36M	$ 130.97M	$ 120.72M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 3.74M	$ 1.48M	$ -1.41M	$ 1.37M	$ 1.34M	$ 1.39M
Net Income From Continuing And Discontinued Operation	$ -1.69M	$ -1.73M	$ -1.60M	$ -1.52M	$ -1.40M	$ -1.99M
Normalized Income	$ -912.48K	-	-	$ -1.52M	$ -1.40M	$ -1.99M
Interest Expense	$ 163.27K	-	-	$ 232.63K	$ 153.41K	$ 87.28K
EBIT	$ -1.36M	$ -1.40M	$ -1.33M	$ -1.29M	$ -1.25M	$ -1.91M
EBITDA	$ -1.36M	$ -1.40M	$ -1.33M	$ -1.29M	$ -1.25M	$ -1.90M

Currency in USD

RegeneRx Biopharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing